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Abstract
Tissue and organ regeneration via transplantation of cell bodies in-situ has become an
emerging strategy in regenerative medicine. Injected or implanted cells must be available in large
enough numbers and suitable delivery methods must be found especially when implantation into
the affected tissue is not possible. In addition, better understanding of how to mitigate the
inflammatory reactions and how to degrade the cell carriers are needed. Current cell-based
therapies are limited to injection or implantation of cell suspensions or implantation of cell
sheets. Development of alternative systems to obtain cell sheets or other functional cellular
structures are required. We are investigating light treatment as an efficient, safe, and repeatable
method to release cells, cellular aggregates, structures or sheets for implantation in regenerative
medicine.
We hypothesize that cells cultured on the surfaces of a photovoltaic element may be
released by applying visible radiation to the element. The light will induce a surface charge on
the element causing cells to be released by electrostatic repulsion. Herein, we conducted a study
that examines the amount and viability of myoblasts cells released from a photovoltaic element
upon light exposure. We investigated (i) the biocompatibility of PV devices, (ii) the utilization of
PV devices as cell substrate iii) the release of attached cells from PV surfaces upon light
stimulation, and (iv) the progressive release of proliferated cells from PV devices. C2C12
myoblast cells were cultured on sterile silicon based photovoltaic elements with n-type surface
under typical cell culture conditions. Upon confluence, the elements were exposed to low power
visible lights for 1-2 hours. Cells in the supernatant and those attached were collected and
counted. In addition live/dead assays and DAPI staining were performed on the released cells.
Cells released by light exposure were re-seeded for further culture. The results showed that
approximately 40% of attached cells could be released from the element upon a light exposure.
This strategy may be used to release cells or cellular structures for eventual use in regenerative
medicine.
vi
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Chapter 1: Introduction
Cell based therapy is the transplantation of cells aiming to prevent organ failures or
malfunctions. Current cell-based therapies are divided into scaffold-based, and scaffold-free
approaches. Scaffold-free approaches include injections of cell suspensions or implantations of
cell sheets. Cell therapies may eventually lead to, artificial or scaffold based organs as a
substitute for organ transplantation [1]. The primary limitation of cell therapies is the inadequate
delivery of nutrients, which not only harms the transplanted cells but may also causes
progressive deterioration of the host tissue. For scaffold based tissue engineering, a major
complicating factor is the inflammatory reactions that take place upon their implantation and
biodegradation of structural materials. Degradation mechanism and byproducts can cause harm
to the seeded cells within the scaffolds limiting the cell mass [2]. Consequently, larger organs
such as the heart, liver, bladder or kidney, have not been re-generated with this method.
Over the last decades, there has been great progress in cell based therapies, especially in
the area of the identification, isolation, and bioprocessing of cells for reconstruction of damaged
organs. One of the key challenges facing the field of cell therapy is to translate in vitro cultures
into an implant that remains functional. Cell therapies often involve injection of cell suspensions
with proper medium into damaged or diseased areas or directly into the systemic blood flow as
shown in (Figure 1.1). Various types of cells including neural stem cells [3], myoblast
populations [4], and a variety of bone marrow derived cells [5] have been transplanted by
injection and were studied with respect to contributing in the restoration of diseased or damaged
tissues. In some cases, the cells attached to target site and some other studies found that injected
cells connected to the existing cell circuitry and improved organ functions [6]. A second
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mechanism has been proposed, which hypothesizes that the injected cells act as reservoirs and
secret growth factors thus participating indirectly in the regeneration of tissues or organs [7-9].

Figure 1.1: Current Strategies for Cell Transplantation [10]

Over the past few decades, biomaterials, including several hydrogels, have been widely
used as carriers for cell delivery or vehicles to promote tissue regeneration [10-12] in cell
encapsulation/delivery systems. Some studies have reported uniform spatial distribution and
localization of cells via direct needle injection at the required site of delivery [9], [14]. Others
have found that systemic administration or targeted delivery can also be performed by infusion
followed by homing [15]. Local infusion and direct injection have the advantage of being
extended from the body surface or through a catheter; however, cells experience small targeting
efficiencies as a high quantity of administered cells are washed out from the blood stream.
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Because of the low targeting efficiencies, this approach has not yet been translated into
regenerative medicine. More efficient delivery and controled release of therapeutic cells are
urgently needed. Studies that look at cell delivery as a function of time, path of administration,
cell density, viability, delivery medium, and accurate spatial distribution to the host site are
necessary [16].

Figure 1.2: Cell-delivery formats can be either scaffold-based or scaffold-free [17].

Two different approaches are employed to carry cells into tissues: (1) transplants
containing cells encapsulated with hydrogels or cells embedded on a scaffold and (2)
transplanting cell sheets and single cells. The former is also known as a scaffold based approach
and the latter as a scaffold free approach.
Largely, the selection of the approach chosen depends on the type of diseases needing
cell-based therapy and what kinds of cells are to be used as therapeutic agents. In single cell
delivery, cell seeding efficiencies, and cell viability are crucial in determining the outcome of the
treatment. Seeding efficacies fluctuate from 0% to 90%, depending on the type of cell, cell
quantity, and methodology used. Cell encapsulation and number of cells to be delivered are also
important parameters, because they determine mechanical properties and reduce pore size, and
3

allow greater retention of proteoglycans [18]. Lastly, the sources of the injected cells are an
important factor because their ease of isolation, in vitro expansion, handling, self-renewal
capacity, and capability to differentiate into various cell types will affect the outcomes.
For scaffold-based approaches, cells are nested in scaffolding materials that provide
biological and mechanical support. A variety of natural extra cellular matrices are used as cell
carriers or vehicles. These include type I collagen and fibrin due to their inherent cell attachment
capabilities. Interactions of the cells with the scaffold materials play a significant role in the cell
attachment and differentiation [19]. For example, it has been shown that the firmness of the
adhesion substrate affects the in vitro differentiation of mature tissue-derived progenitor cells
[20]. Cell adhesion, therefore, impacts the capacity of forming new tissue structures and
contribute in regeneration of injured tissues [19]. In addition to collagen and fibrin, other
hydrogels and various stimulus responsive biomaterials are used for cell encapsulation.
Encapsulated cells are used in a wide range of application in the cell therapy [21]. However,
assembly of encapsulated cells is a tedious process and the design of proper delivery systems is
required. Commonly used stimulators or triggers holding encapsulated cells include temperature
for collagen [22] and Matrigel [23], pH change for PuraMatrix [24], leucine-zipper systems [25],
boosting of cation concentration for alginate [26] and peptide amphiphiles [27]. As cells are
highly sensitive to external stimulus and abrupt changes in physiological state, these triggers can
be harmful to the encapsulated cells and associated protein. In some cases the intensity of
external stimulation can cause severe toxic immunogenic or mutagenic reactions.
Both encapsulated and scaffold free cells delivered via intravenous injection are
distributed systemically, and merely a small portion of the injected cell dose reaches the intended
destination for regeneration [28]. Additionally, even when a small portion of the cells reach the
4

target tissues, their restorative or healing activities can be extremely short-lasting and frequent
repeated dosing can be required.
A significant challenge to the successful implementation of cell therapies is the
integration of delivered cells with the host. Cells need to integrate quickly with the host’s
lymphatic, vascular, and nervous systems. Rapid attachment and adjustment of cells must occur
to avoid anoikis or programmed cell death. Transplanted cells will die quickly if they are not
delivered to the targeted side or within 100 µm from tissue vasculature. However, several studies
have shown that survival can be improved by over expression of pro angiogenic factors [8], [2931].
Although cellular therapy has great deal of potential, there are still the following
noteworthy challenges to overcome:
•

Designing cell specific biomaterials for scaffold-based regenerative treatments

•

Noninvasive administration or transplantation with high dose of cells and therapeutic
efficacy

•

Most fitting cell type and timing of treatment

•

Design new delivery systems that integrate various cues for cell homing

•

Identifying suitable biocompatible and biodegradable materials for anchorage
dependent cells as cell carrier or vehicle

•

Cell release from the cell-substrate with external stimulation

Anchorage dependent mammalian cells are greatly affected by cell–substrate interactions
[32]. Various hydrogels have been used for biomedical applications, but biocompatible silicon
substrate exhibits a unique potential in adherence and viability of cells [33] and has been very
5

little explored until the present time. In this study, we test whether biocompatible silicon based
Photovoltaic (PV) devices that serve as cell culture substrates can be used as cell delivery vehicle
or carrier. Monocrystalline silicon cell culturing surface charges can be manipulated with light to
reveal mechanistic information on action potential cell fate such as linkage, release and
migration. Photovoltaic cells are devices that convert light into voltage as well as induces charge
transport by the photovoltaic effect [34]. Therefore, silicon based PVs have the potential to serve
as a new cell vehicle or carrier to culture cells, and releases them upon external photo
stimulation. The ultimate goal of this study is to develop a cell release mechanism based on light
activated photovoltaic devices. We are investigating if the charged anchorage dependent cells
can be released from the PV device upon light exposure.
1.1

Cell therapy as therapeutics
Existing therapeutic approaches to healthcare and medicine have been very efficacious in

developing new treatments for various critical and chronic disorders or infections. However,
numerous patients are suffering without proper treatment from lingering illness. Successful
regenerative treatments and cell therapies could greatly improve the diseases and conditions of
innumerable patients by enhancing the quality of life. Considering the root cause syndrome at
cellular level, cell therapies have the strong effect to cure or reduce the ailment of some chronic
and critical conditions including trauma, heart disease, progressive neurological disorder, and
autoimmune diseases. At present, 13% of US population are older than sixty five years of age
and this percentage is going to jump on 19% in next two decades [35]. As a result diseases such
as cancer, diabetes, heart disease, stroke, pulmonary disease will remain high in prevalence.
Furthermore, older people are also susceptible to degenerative diseases such as Alzheimer’s
disease (AD), amyotrophic lateral sclerosis (ALS), Parkinson’s disease (PD), and Huntington’s
6

disease (HD). The treatment of those chronic and neural diseases is that of care either in a
clinical setting or at home to relieve symptoms, rather than a cure. This will burden the US
healthcare system with increased healthcare spending that is predicted to rise sharply both on a
per capita basis and as a percentage of the US federal budget.
1.2

Justification of the work
The major outcome of regenerative medicine is to directly improve health condition by

wound repairing or replacement and corresponding economic savings. Despite the huge
potential, few regenerative treatments or products are in the market. Two of the major hurdles
are the estimated one billion dollar cost, and regulatory compliance with the Food and Drug
Administration (FDA). Therefore, most challenging aspects of developing novel therapy is that it
has to be economically viable, effective, safe as well as easy to produce. Existing regenerative
treatments for organ repair or replacement is not only in short supply, there are also processing,
economical, medical, ethical, pre-operative and postoperative issues.
In the current cell delivery methods, cell loading, cell release, cell dose, timing of
administration and cell encapsulation are an intricate manufacturing process. The cells used for
regenerative therapy may die during cell processing and pose a challenge to interact with
substrate materials. Furthermore, there are other limitations that include optimal delivery
methods, insufficient localization, cell retention, cell survival, and lack of a matrix for cell
attachment that can result in cell death [36]. To achieve a simple and safe process for cell-based
therapies, new tools and technologies are needed. Our novel study, development of a light
stimulated cell release mechanism from PV devices, might be able to resolve current cell
delivery obstacles. We strongly believe that current noninvasive cell release method will lead to
establish a robust and viable system for cell release with better cell survival and engraftment.
7

References
1.

Tabata, Y., Significance of release technology in tissue engineering. Drug Discov Today,
2005. 10(23-24): p. 1639-46.

2.

Sung, H.-J., et al., The effect of scaffold degradation rate on three-dimensional cell
growth and angiogenesis. Biomaterials, 2004. 25(26): p. 5735-42.

3.

Johansson, C.B., et al., Identification of a neural stem cell in the adult mammalian central
nervous system. Cell, 1999. 96(1): p. 25-34.

4.

Partridge, T.A., et al., Conversion of mdx myofibres from dystrophin-negative to positive by injection of normal myoblasts. Nature, 1989. 337(6203): p. 176-9.

5.

Krause, D.S., et al., Multi-organ, multi-lineage engraftment by a single bone marrowderived stem cell. Cell, 2001. 105(3): p. 369-77.

6.

Hou, D., et al., Radiolabeled cell distribution after intramyocardial, intracoronary, and
interstitial retrograde coronary venous delivery: implications for current clinical trials.
Circulation, 2005. 112(9 Suppl): p. I150-6.

7.

Rehman, J., et al., Peripheral blood "endothelial progenitor cells" are derived from
monocyte/macrophages and secrete angiogenic growth factors. Circulation, 2003. 107(8):
p. 1164-9.

8.

Rehman, J., et al., Secretion of angiogenic and antiapoptotic factors by human adipose
stromal cells. Circulation, 2004. 109(10): p. 1292-8.

10.

Mooney, D.J. and H. Vandenburgh, Cell delivery mechanisms for tissue repair. Cell Stem
Cell, 2008. 2(3): p. 205-13.

11.

Drury, J.L. and D.J. Mooney, Hydrogels for tissue engineering: scaffold design variables
and applications. Biomaterials, 2003. 24(24): p. 4337-51.

8

12.

Mellott, M.B., K. Searcy, and M.V. Pishko, Release of protein from highly cross-linked
hydrogels of poly(ethylene glycol) diacrylate fabricated by UV polymerization.
Biomaterials, 2001. 22(9): p. 929-41.

13.

Peppas, N.A. and W. Leobandung, Stimuli-sensitive hydrogels: ideal carriers for
chronobiology and chronotherapy. Journal of biomaterials science Polymer edition, 2004.
15(2): p. 125-44.

14.

Mangi, A.A., et al., Mesenchymal stem cells modified with Akt prevent remodeling and
restore performance of infarcted hearts. Nature medicine, 2003. 9(9): p. 1195-201.

15.

Al Mheid, I. and A.A. Quyyumi, Cell therapy in peripheral arterial disease. Angiology,
2008. 59(6): p. 705-16.

16.

Gill, S.S., et al., Direct brain infusion of glial cell line-derived neurotrophic factor in
Parkinson disease. Nat Med, 2003. 9(5): p. 589-95.

17.

Kelm, J.M. and M. Fussenegger, Scaffold-free cell delivery for use in regenerative
medicine. Advanced drug delivery reviews, 2010. 62(7-8): p. 753-64.

18.

Hoemann, C.D., et al., Tissue engineering of cartilage using an injectable and adhesive
chitosan-based cell-delivery vehicle. Osteoarthritis Cartilage, 2005. 13(4): p. 318-29.

19.

Yeo, C. and A. Mathur, Autologous bone marrow-derived stem cells for ischemic heart
failure: REGENERATE-IHD trial. Regen Med, 2009. 4(1): p. 119-27.

20.

Snowden, J.A., E. Martin-Rendon, and S.M. Watt, Clinical stem cell therapies for severe
autoimmune diseases. Transfus Med, 2009. 19(5): p. 223-34.

21.

Nicodemus, G.D. and S.J. Bryant, Cell encapsulation in biodegradable hydrogels for
tissue engineering applications. Tissue Eng Part B Rev, 2008. 14(2): p. 149-65.

9

22.

Spencer, N.J., D.A. Cotanche, and C.M. Klapperich, Peptide- and collagen-based
hydrogel substrates for in vitro culture of chick cochleae. Biomaterials, 2008. 29(8): p.
1028-42.

23.

Lu, W.N., et al., Functional improvement of infarcted heart by co-injection of embryonic
stem cells with temperature-responsive chitosan hydrogel. Tissue Eng Part A, 2009.
15(6): p. 1437-47.

24.

Wuertz, K., K. Godburn, and J.C. Iatridis, MSC response to pH levels found in degenerating intervertebral discs. Biochem Biophys Res Commun, 2009.379(4): p.824-9.

25.

Vanderhooft, J.L., et al., Rheological properties of cross-linked hyaluronan-gelatin
hydrogels for tissue engineering. Macromol Biosci, 2009. 9(1): p. 20-8.

26.

Boontheekul, T., H.J. Kong, and D.J. Mooney, Controlling alginate gel degradation
utilizing partial oxidation and bimodal molecular weight distribution. Biomaterials, 2005.
26(15): p. 2455-65.

27.

Hancock, R.E. and H.G. Sahl, Antimicrobial and host-defense peptides as new antiinfective therapeutic strategies. Nat Biotechnol, 2006. 24(12): p. 1551-7.

28.

Chen, J., et al., Therapeutic benefit of intravenous administration of bone marrow stromal
cells after cerebral ischemia in rats. Stroke, 2001. 32(4): p. 1005-11.

29.

Huang, Y.C., et al., Combined angiogenic and osteogenic factor delivery enhances bone
marrow stromal cell-driven bone regeneration. J Bone Miner Res, 2005. 20(5): p. 848-57.

30.

Tateishi-Yuyama, E., et al., Therapeutic angiogenesis for patients with limb ischaemia by
autologous transplantation of bone-marrow cells: a pilot study and a randomised
controlled trial. Lancet, 2002. 360(9331): p. 427-35.

10

31.

Kalka, C., et al., Transplantation of ex vivo expanded endothelial progenitor cells for
therapeutic neovascularization. Proc Natl Acad Sci U S A, 2000. 97(7): p. 3422-7.

32.

Gumbiner, B.M., Cell adhesion: the molecular basis of tissue architecture and
morphogenesis. Cell, 1996. 84(3): p. 345-57.

33.

Fan, Y.W., et al., Culture of neural cells on silicon wafers with nano-scale surface
topograph. J Neurosci Methods, 2002. 120(1): p. 17-23.

34.

United States. Congress. House. Committee on Transportation and Infrastructure.,
Photovoltaic system for Department of Energy Headquarters building : report (to
accompany H.R. 798) (including cost estimate of the Congressional Budget Office), in
Report / 110th Congress, 1st session, House of Representatives 110-11. 2007, U.S.
G.P.O.: Washington, D.C.

35.

Vincent, G.K.a.V., Victoria A, The Next Four Decades, The Older Population in the
United States: 2010 to 2050. U.S. Census Bureau, 2010.

36.

Weisel, J.W., The mechanical properties of fibrin for basic scientists and clinicians.
Biophys Chem, 2004. 112(2-3): p. 267-76.

11

Chapter 2: Literature Review

Organ or tissue regeneration by cell therapy is called regenerative medicine. Key goal of
regenerative medicine is the management of sustainable biological function by repairing,
replacing, and regenerating cells, tissues or organs. This is accomplished by introduction of cells
to the damaged tissues or organs combined with therapeutic agents. Most of the research in
regenerative medicine centers around finding biocompatible cell friendly systems for delivery,
proliferation, and restoration of an existing organ [1]. Degenerative diseases and malfunctioning
or damaged organs may be treated with cells that can be autologous, or stemming from the same
individual, allogeneic, stemming from the same species, or xenogeneic, stemming from a
different species.
Organ transplantation is extensively performed globally and each day 79 people receive
organ transplants. In most of the cases organ transplantation is the only viable solution for the
treatment of organ failure. The number of organs available for transplantation is much less than
the number required, and this discrepancy is turning into one of the most important crises in
nearly all countries of the world. Most of the patients on the organ donor waiting list die before a
suitable transplant becomes available and currently the ratio of organ donor to receiver is 1:
100,014 [2]. According to United States ‘Organ Donation and Implantation Statistics” in May
21. 2014, there are a 122,737 people waiting for lifesaving organ transplants in the U.S [3].
Furthermore, obtaining the organs for transplantation necessitates intricate surgeries to collect
the organs from the donor. This organ removal procedure must follow legal and ethical issues, as
well as the definition of death and consent.
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Globally the direct healthcare costs of organ transplants are about $350 billion and the
USA is spending more than $100 billion per year for organ transplant related expenditures and
therapies [4]. In the developed countries, the elderly are suffering from organ malfunctions or
damage; with 8 million spend on surgical procedures annually to treat those patient [5]. As the
older population in the US is growing fast, by 2040, the total number of senior citizens suffering
from organ malfunction diseases is expected to jump to 70 million and corresponding health care
costs are forecast to be 25% of GDP [6].
Apart from donor shortages and increased expenditures, after organ transplantation
patients or organ recipients must have lifetime immunosuppression treatments which have side
effects, or complications include infections, and the growth of tumors. Noninvasive surgical
procedure for organ transplantation also experiences deficiency of donor tissue and donor site
morbidity [7].
2.1

Xenotransplantation and artificial organ as organ donor
The gap between organ donors and recipients is widening and without foreseeable growth

in organ donors, it is necessary to reduce the dependency on organ donation and prompt
alternative solution such as Xenotransplantation (animal to human), artificial organ (fabricated
biomechanical devices/organ), gene therapy, and regenerative medicines. Xenotransplantation
has a long history since sixteenth century, when animal blood transfusions and bone transplants
to human were performed [8]. Xenotransplantations are still rare because the large immune
response and the possible spreading of donor animal viruses to organ recepients [9-11]. Without
proper diagnosis, malignancies or infections originated from the donor organ may be transmitted
to recipients, triggering severe illness even patient death[12, 13].
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The development artificial organs will reduce the dependency on organ donors. Artificial
organs are made in laboratory form various types of biomaterials.

At present artificial

mechanical devices that carry out the function of organs have considerable unwanted side effects
and same time reduces the quality of life. However, they sustain life and, with further advances
in nanotechnology, stem cells, genetic science, diagnostic, and sensing technologies artificial
organs may save millions of critical patience from early death [14].
2.2

Regenerative medicine (RM)
Regenerative medicine is a term that encompasses cell therapy, organ repair, and organ

transplantation with various sources. Its goal is to regenerate defective organs, tissues, and cells,
by employing cell-based therapies, biomolecular drugs or even medical devices to establish
regular function. Cell based therapies promise to offer reliable restorative tools that may be
considered for patients at the last stage if their disease [15]. The degenerative diseases targetted
by cell based therapies are those involving cells that don’t regrow by themselves, such as βcells, schwann cells, cardiomyocytes and urothelial cells for bladder. A possible solution for
these diseases is restoration of damaged cells or tissues by administering healthy donor cells.
Regenerative medicine has the potential to cure these illnesses by restoration malfunctioning
tissues, provided a good source of cells can be found. Although regenerative medicine is in its
infancy state, in recent years significant advances were made in designing novel biomaterials
[12], developing new cells delivery mechanism and in characterizing and isolating stem cells as a
source of donor cells [16]. Thus regenerative medicine is potentially substituting the organ
requirement for transplantation.
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2.3

Cell therapy as regenerative medicine
Cell therapy is a subgroup of regenerative medicine, simply defined as the procedure of

introducing new cells as therapeutic agents into a damaged tissue aiming to treat disease. It
includes the delivery of progenitor cells or stem cells from autologous or allogenieic cell sources
into a transplant in vitro and in vivo [17]. Precursor of modern cellular therapy was pioneered in
early 1950 [18], currently achieved milestone progress in cell transplantation from both
autologous [19], and allogeneic cell [20] sources. At present biomedical scientists are conducting
intensive research in cell-based regenerative therapeutics using non-specialized cell such as
autologous and allogeneic cell sources. This therapeutics has been developed to commercialize
various cells to improve patient care as well as treating diseases suffering from cell damages.
These non-specialized biological cells are very potential to transform into the primary layers of
cells from tissues by self-renewal process and provide an infinite source of clinically usable cells
for regenerative medicine. Advances in stem cell biology and immunology have significantly
ensured the high quality application of cell transplantation as a curative approach.
The omnipotent stem cell is called the mother of cells, because it has the potential to
differentiate into specific cell types such as brain, bones, heart, blood, skin, and muscles. Sources
of adult stem cells are bone marrow, fat, skeletal muscle, hair follicles, dental pulp, and other,
but these are not omnipotent, and some are only giving rise to one specialized cell type. All stem
cells have self-renewal capability for long periods, can proliferate extensively and can give rise
to specialized cell types. Some studies have examined the effect of stem cells injected into the
heart [21] and others looked at their effect on neural diseases like Alzheimer’s disease (AD) [22],
amyotrophic lateral sclerosis (ALS) [23, 24], Parkinson’s disease (PD) [25], Huntington’s
disease (HD) [26], and spinal cord injury [27]. Successful delivery of stem cells can treat all the
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diseases, as they are capable of differentiating into required cell types. In post-delivery stage,
these mature cells replace tissues and can produce insulin that is damaged by disease or injury.

Figure 2.1: Potential of stem cell (Source: National Institutes of Health, Bethesda, MD)

Cell therapy is divided into two modes. In the first mode cells are injected systemically or
locally to the site of injury. The delivered cells participate in the healing mechanism by
integrating into injured regions and or replacing the damage tissues [28, 29]. In the second mode,
delivered cells remain at the injury sites for comparatively small period of time and die within a
few days to weeks without further differentiating. Prior to their death cells, they release
therapeutic agents such as growth factors; chemokines, and cytokines to aid in the reconstruction
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of native tissue [30, 31]. A wide variety of cells types such as neural stem cells [33], myoblasts
[34], bone marrow-derived cells [35], and embryonic stem cells [36] have been transplanted as
cell therapy. Most of the cells remain in circulation system during post-delivery. Studies have
demonstrated that therapeutic action of delivered cells is low, because 75- 90% cells die prior to
arrive at the site of injury or damaged area [37].

2.4

Cell delivery methods
Depending on the nature of the injury, type of damage, and its location, various types of

cellular constructs can be chosen, each of them having a particular delivery method associated
with it. Selection of the delivery method aims at high cell retention, minimal side effects, and
high cell survival rates. In addition, the delivered cells must incorporate with the host tissue near
the injured region. Two types of cell methods are used in cell therapy: (i) Scaffold based,
consisting cells and biomaterials [38], and (ii) biological cell and/or full tissue engineered cell
assemblies [39]. Most common are delivery into the diseased tissue directly by intraarticular,
intramuscular or intratendinous injection of cells [40]. In some cases, the damage sites
necessitated filling or bridging materials in addition to cells, and therefore, cells needed to be
delivered together with a matrix [41, 42]. In most cases, this matrix, or scaffolding, serves as a
transient support for cells to attach and produce new, organ or tissue-specific extracellular
matrix. Scaffold materials must have suitable surface chemistry and the required mechanical
strength to promote these cellular activities [43, 44]. A large number of natural and synthetic
materials, including some composite materials have been used as scaffolding material described
below.
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2.4.1

Scaffold based cell delivery
Biocompatible scaffolds serve as cell carrier or vehicles for cell delivery. Engineered

scaffolds must supply a microenvironment to support cell/tissue growth during the delivery and
transplantation stages. Scaffolds can be solids,, nutrient loaded microspheres or gels. Figure 2.2
shows the different forms of scaffolds used as cell delivery vehicles [45]. As a major structural
component of the extracellular matrix, collagen type I, and type II are also responsible for cell
attachment, proliferation, and differentiation via cell–matrix interactions [46]. Both these
collagens are widely used in cell delivery applications, in particular for tissues of the

Figure 3 Scaffold based cell delivery vehicles [61]

Figure 2.2: Scaffold based cell delivery vehicles [46]

musculoskeletal system [47-50]. They are also used to encapsulate growth factors and cells,
which is done in small droplets, microparticles or beads [51-53]. In addition, other natural
materials such as ﬁbrin [54], chitosan [55], chondroitin sulfate (CS) [56], and hyaluronan,
alginate [57] are used as scaffolding materials. Synthetic biomaterials are also used for targeted
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delivery. They offer the advantage that they can be modified chemically to allow for cell
specific interactions and they have better mechanical properties compared to natural
biomaterials. Most commonly used synthetic biomaterials used as cell delivery vehicles or
structural support are polylactic co glycolic acid (PLGA) [58], polycaprolacton (PCL) [59],
polyethelene glycol (PEG) [60] and ceramics materials [61].

2.4.2

Scaffold free Delivery System
Scaffold based cell constructs provide initial mechanical and structural support, however,

there are still some potential issues regarding with their biocompatibility, biodegradability, and
long-term safety. To bypass those risks, scaffold-free cell delivery has been explored as an
alternative. Currently three types scaffold free delivery methods are tested in preclinical and
clinical trials: (i) ejection of single cells (ii) cell sheet technology and (iii) microtissue
technology. These will be briefly reviewed next.

2.4.2.1

Single cells delivery

Scaffold free single cell suspensions are directly delivered to the damage site or tissue via
intravenous or intra-arterial injections. The types of cells injected are chosen based on their
differentiation potential and the accessibility of the targeted host tissues that requires repair.,
Direct injection of cells is foremost used for non-vascularized tissues such as intervertebral discs
[70] or cartilage [63]. Other target tissues included the pancreas [62], cartilage [63], heart
myocardium [64-66], peripheral arteries [67], blood [68], and brain [69]. In these letter cases, the
injection can by systemic via intraperitoneal, intravenous or intra-arterial routes, offering the
advantage of being less invasive [72]. Systemic cell delivery is best suited for delivery of stem
cells such as mesenchymal stem cells [73, 74], or hematopoietic stem cells [74, 76]. In the single
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cell delivery systems the injected cells and the host cells interact quickly, however, there is low
integration into host tissues and high cellular wash out. Thus very high cell dosages are required
for therapeutic success and small dosage results in poor grafting. However, multiple injections
using a intracoronary route may have been related to ventricular arrhythmias [77]. Consequently,
this delivery method is not widely used and necessitates the investigation of more effective
technologies of cell delivery.

Figure 2.3: Single cell delivery into various tissues [71].

2.4.2.2

Cell sheets delivery
Cell sheet delivery is accomplished first culturing cells until confluence, then detaching

the confluent layer from the culturing substrate. The resulting sheet of cells is then transplanted.
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Over the last decades in vitro grown cell sheets have been used to regenerate various types of
tissues, including corneas [78], full biological small diameter vessels [38], cardiac tissues [16],
and whole pancreas [79]. The sources of cells included limbal stem cell, human vascular smooth
muscle cells, endothelial cells, beta cells and myocytes. The most common method to collect the
cell sheet is to use a thermo reversible material as the cell culturing substrate. When the cell
sheet is ready to be collected, the temperature is dropped from 36o to 25oC and the cell sheet
floats to the surface of culture dish. Kushida and coworkers developed cell sheet from a
temperature-responsive polymer culture surface [80] using human [81] or rabbit limbal cells
[78].

Figure 2.4: Organs for cell sheet delivery to make various bio-processed organs [71].

Cell sheets are also fabricated from magnetization and demagnetization of RGD (ArgGly-Asp) coated cell culture surfaces [82]. Laboratory grown cell sheet have been used to
generate or repair cardiac [16], cornea [78], skin [83], esophagus [84], and many more. Cell
sheets harvested from cell culture substrates are used to produce three dimensional tissues by
stacking [16] to standard patches have been made from MSCs [85], fibroblast-endothelial
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cocultures [86], neonatal cardiomyocytes [87], skeletal myoblasts [88, 89], or neonatal rat
cardiomyocytes endothelial cell cocultures [90]. Cell sheet mediated regenerative approach has
huge prospect, however, some limitation need to be addressed such as cell sheets’ flimsiness and
handling problem throughout surgery [89].

2.4.2.3

Micro-tissues
Micro-tissues are cell clustered normal tissue constructs sized between 100 µm and 500

µm in diameter or thickness generated from individual cells under regulated cell culture
conditions. Surgically implantable microtissues can be made from adherent stem cells [91], cell
lines [92], and other tissues of interest [93]. Typically, the cells are placed on a non-adherent
dish, where the cells form spheres, spheroids, or aggregates (Figure 2.5) [94]. The Injection of
microtissues is minimally invasive; furthermore, they offer significant advantages over single
cell or cell sheet delivery. Microtissues do not wash out as much as single cell due to relatively
larger size. As a result, they adhere faster to extracellular matrix [95] and graft more efficiently
to the host tissues.

Figure 2.5: Overview of microtissue delivery to repair organ [71].
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One of the major concerns in transplantable microtissue, is vascularization, without
which the microtissues cannot survive. Microtissues have been shown to generate vascular
endothelial growth factor that induces angiogenesis after implantation [96, 97]. Layering of
microtissues can also be done. Kelm et al. generated living small diameter blood vessels from
Human artery-derived fibroblasts and endothelial cells that mimic the native blood vessel
morphology. These small diameter grafts offer a huge advantage in comparison to the synthetic
grafts used today [95].

2.5

Cell delivery techniques

Regeneration of cells by therapeutic cell delivery advanced the field of regenerative medicine.
Currently several types of cell delivery strategy are available; intravenous infusion [98], surgical
direct injection [99], catheter based delivery [100], and engineered cell delivery [101]. injection
[99], catheter based delivery [100], and engineered cell delivery [101]. The intravenous cell
delivery process is noninvasive; however, the efficacy is limited because cells tend to cluster
before spreading to the target site. Cell delivery during surgery results in high cell engraftment
and viability, but there is potential risk associated with the surgical procedure. Catheter based
delivery releases cells near the target sites, but the catheter can cause microembolisms and it
can’t be used if the artery occluded. Current research focuses on improving techniques for better
cell grafting in the target region and improved therapeutic effects of the delivered cells. Table 3.1
shows the advantages and disadvantages of the various cell delivery systems. Using engineering
cell delivery the release of the cells can be better controlled and the cells can be directed to the
target site by external modulation, potentially improving both grafting and therapeutic effects.
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Figure 2.6: Cell delivery strategy for regenerative cell therapy, A [98], B [99], C [100], and D [101].

Table 3.1: Summary of existing cells delivery methods.

Cell delivery
method
Surgical
delivery method
[102]

Advantages
§

§

Disadvantages

The most direct cell delivery

§

Noninvasive operation required.

process.

§

High risks for side effect and

Precise and accurate

mortality.
§

approach.
§

No troubling of surrounding
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Reduced cell retention to target
side.

tissue and vasculature.
Catheter-Based
cell
Administration
[103]

§

Repeatable as required due to

§

its less invasiveness
§

Requires extensive imaging
guidance.

Low risk for potential wall

§

perforations.

Limited by the scope and
development of catheter
technology.

Intravenous
Injection [104]

§

Safe and feasible

§

No arrhythmias

§

Greater cell retention.

§

right territory.
§

Noninvasive delivery route.
Engineering cell
delivery [103]

§

Difficult to deliver cells to the

during delivery.
§

Great potential for

Induce shear stress to the cell

regeneration.

Still in infancy level, leaving
more questions than answers.

§

Better cell entrapment.

§

Huge room available for

§

More inquiry required to validate
clinical potential

improvement.

2.5.1

Cells directing by external modulation
The fundamental strategy of directing injected cells by external modulation is the subject

the cell carriers to various physical stimuli which can be controlled externally. This allows more
accurate cell delivery. Externally applied stimuli include light, magnetic, thermal, and
electrochemical, but this review will be limited to magnetic and thermal stimuli.
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2.5.1.1

Cell release controlled by magnetic force
In vitro studies show that magnetic beads that can be used to label cells, also serve as

good carriers for delivery of mesenchymal stem cells (MSCs). Magnetically labeled MSCs
exhibit better extraction or release rates from the petridish when they are located in an external
magnetic field [106]. Kobayashi T. et al [107] investigated the delivery of MSC’s labeled with
magnetic beads to treat osteochondral defects by intra-articular cell injection. The group used
ferumoxides, super paramagnetic iron oxide nanoparticles, that were coated with dextran and
poly-L-lysine (PLL). The particles could act as a transfection agents, entering MSCs and also be
guided by an externally applied magnetic field.

Figure 2.7: Magnetically cell delivery principle and the experimental procedure [107]
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into osteochondral defects. This new cell delivery process by magnetic force is very promising
for cartilage repair, or osteochondral restoration; however, the authors identified some issues that
needed to be properly addressed. The needle or catheter must be nonmagnetic, the lipid bilayer
cell membrane may be damaged by inappropriate magnetic force and the, magnetic force might
induce the accumulation of all cells in some spots rather than inducing a uniform distribution. In
addition, cell viability was not properly addressed in this study.

2.5.1.2

Cell sheet released with temperature modulation
Temperature sensitive cell culturing dishes were used for cell sheet release studies. The

key to the innovation is the use of temperature-sensitive materials as cell culture substrates [108].
As one example, Nishida et al. [78] grew corneal epithelial cells on temperature-sensitive
petridishes for 2 weeks., Cell sheets were detached from the culturing surface by reducing the
temperature to 25°C , collected and implanted cornea of rabbits whose rabbits’ conjunctival
tissue had been removed. Cells transfer with this procedure was robust, and multilayered cell
sheets promoted restoration of the corneal stroma in vivo without major surgical operation. Even
though the cell sheet procedure is non-invasive, the delivery of the sheets pose a problem, as
many potential sites cannot be accessed by a catheter or are as openly accessible as the eye. One
potential problem with the technique is the induction of cold stress due to the temperature
reduction. Cold stress might interfere with the normal biological function cells or tissues.
Furthermore, in vitro to in vivo handling and implantation of the harvested cell sheets is very
risky. Wrinkle or folding of cell sheets or cell damage might lead to scar tissue on the implant.
Furthermore, cells cannot grow beyond a monolayer or on the top of each other.
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Figure 2.8: Cell delivery as cell sheet with the aid of temperature reduction [78]

The physically modulated approaches described above provide several advantages for
cell injection and tissue reconstruction; however, some limitations remain. One of the major
problems is the considerable amount of cell loss; only a small fraction of cells are available for
the regeneration process at the targeted site. In addition, in injured tissues, the cell supportive
structure is already damaged and transferred cells are often not able to attach to the injured
architecture. Cell sheet production requires long time and is susceptible to damage or
disintegration through handling [39], [89]. Furthermore, the cells can be affected by cold stress
and it can potentially damage cell membranes. Therefore, cell delivery by physically modulated
approaches often result in random outcomes after implantation.
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2.6

Silicon based PV device and its biological interaction
Silicon has seen increasing use as a biomaterial in a wide range of biomedical devices.

Some examples are implantable sensors [109], neural electrodes [110], and devices for drug
delivery [111], In addition, micro electro mechanical systems are made from crystalline silicon
and they have been found to be biocompatible. Apart from biocompatibility, semiconducting
properties of silicon are used in photovoltaic (PV) devices. With exposure of light PV generate
electricity by the photovoltaic effect creating a voltage difference [112] in between n-type and ptype doped regions; one exhibiting an excess of electrons, the other an electron deficit,
respectively referred to as n-type doped and p-type doped [113] shown in Figure 2.9. By placing
metallic contact on the n and p regions, a diode is obtained. When the junction is illuminated,

Figure 2.9: Cross section of Silicon based PV devices that generate voltage on the between top and
bottom surface.

photons yield their energy to the atoms, each photon causing an electron to move from the
valence band to the conduction band, leaving behind a hole, which also allows it to moves
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around the material, thus giving rise to an electron-hole pair. Because of the circuit at the cell’s
terminals, electrons from the n region will migrate back to the holes in the p region, and it raises
the voltage difference by passing electron through circuit [114].

2.7

Electrically excitable cells
Electrically excitable cells are specialized cell in which the cell membrane is polarized

and can be depolarized and subsequently repolarized. Cell membranes are made up of lipid
bilayers, and ion channels that are located in cell membrane as macromolecular pores.

Figure 2.10: Action potential of electrically excitable cells (Source: Pearson Education Inc.)

The ion channels control ion exchange, and thereby the electrical potential of cell
membrane [115]. Voltage-gated ion channels are governed by electrical signals to transfer of
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specific ions such as Na+ and K+ [116]. In the cells, concentration of ions varies with time and
depending on location compare to membrane. Na+ is abundant in outside of cell membrane
compare to inside of ell. However, for K+ the ionic concentration is opposite. Intracellular K+
concentration higher compare to outside of cell membrane. As result in normal unexcited state
cell membrane has an electrical potential of -70mV due to ionic concentration gradient. In
excitable state depolari-zation causes an intracellular flow of Na+ via sodium ion channels make
more positive or less negative followed by out ward movement of K+ ion causes repolarization
and hyperpolarization making more negative membrane potential [117]. Action potential in cells
is defined as a transient phenomena in which electrical potential or voltage of a cell membrane
sequentially rises and falls in a rapid manner [118]. Action potentials take place in muscle cells
[119], fertilized eggs [120], neurons, [121], and endocrine cells [122].
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Chapter 3: Hypothesis and Objective
3.1

Hypothesis
It is hypothesized that light responsive biocompatible photovoltaic devices can be used as

substrates for culturing of biological cells. Upon successful culturing of living cells, light
stimulation can be used to release cells by electrical charge repulsion.
We will explore whether the biological cells are able to be cultured on the PV devices or
not. And if we are successful in culturing the cells, we will test if they can be efficiently removed
from the culturing surface upon light exposure or photon stimulation. To proof the concept, we
will first conduct biocompatibility tests with a range of nontoxic commercially accessible
photovoltaic devices. In these tests, we will determine if the cells can attach to the surfaces of the
PV devices.
We will then select the most biocompatible devices and study whether; C2C12 cells can
be grown on the devices. After attaining semi-confluence or confluence level, we will induce
electrical charges on the device surface by exposing the device to light. Any released cells will be
analyzed as shown in Figure 3.1. The fundamental goal of this investigation is to develop a
controlled cell release device.
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Figure 3.1: PV effect and cell culturing on PV devices

3.2

Objective
a. Assessing biocompatible PV devices: To assess the biocompatibility, various PV
devices made of nontoxic material were evaluated. C2C12 cells were cultured with
small pieces of PV devices and microscopically observed for 2 weeks to detect any
harsh effect on cells and cells normal growth profile.
b. Cell culturing on photovoltaic devices: Upon successful assessing of PV devices,
C2C12 cells were cultured on PV substrate to observe cells growth profile, cell
viability, live/dead assay and total cells count up to confluence level
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c. Release of attached cells using light source: Cells cultured on PV were released or
detached with light sources at confluent cell cultured. Cells count of released cells
was compared with total number of attached cells, cells in dark group (non exposure
of light) and cells released by enzymatic process by trypsin.
d. Progressive release of proliferated cells from PV devices and increases the
stability phase of cell growth curve: Growth profile, quantitative and qualitative
analysis of remaining cells attached to PV devices after periodically light exposure
were evaluated to increase stability phase (without death phase) for successive cell
release by nonenzymatic process.
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Chapter 4: Materials and Method
In this section, the protocols used to accomplish our goal are described. Preparation of
silicon devices as cells substrates, and biological cell seeding on these devices are detailed. The
cell release procedure from the culturing devices using light as photo simulation as well as
histological and morphological analysis also discussed.
4.1

Materials

4.1.1

Photo voltaic cells
For the experiment we used Photovoltaic cells obtained from RadioShack® (Fort Worth,

TX). Monocrystalline silicon based porous PV are made of single crystal structured that shows
maximum open circuit surface voltage 0.55VDC in full sunlight (100 Klux), and maximum
current 0.25 to 0.275 amps. However, the surface voltage is variable with various light intensities

Figure 4: Silicon based PV cells

4.1.2

A boundary wall surrounding the PV cells was made with glue to protect the

culturing medium and cell solution from leaking out of the culturing surface. The small round
glue sticks was manufactured by Ad tech ™ (Adhesive Technologies Inc., Hampton, NH). The
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clear easy bonding adhesive sticks were made from non-toxic material and their melting point is
92°C. Acrylic polymer based adhesive was applied with glue gun to yield a wall of 2 mm thick
and 3 mm in height. The curing process of glues was 2 minutes.

Figure 5: Ad tech glue sticks (Adhesive Technologies Inc.)

4.1.3

C2C12 Cell
Anchorage dependent myoblasts C2C12 mammalian were obtained from American Type

Culture Collection, ATCC

(CRL-1772) grown in Dulbecco's Modified Eagle's Medium

(DMEM) augmented with 1% antibiotics, 2mM glutamine, and 10% fetal bovine serum; the pH
was adjusted to7.5. The cell line was incubated in an incubator, maintaining 5% CO2 atmosphere
at 37°C, and 100% humidity. Two of the key characteristics of C2C12 cells are that they are
electrically excitable and capable of differentiating in culturing environment.
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Figure 6: Differentiated C2C12 cells (Source: McGowan institute of regenerative medicine)

4.2

Bio compatibility test

Figure 7: C2C12 cells were cultured with small pieces of PV cells (left) and Glue (right)
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Materials mostly used are of certified nontoxic condition from the suppliers. However,
for the experiment, we need to verify toxicity and biocompatibility of the PV devices. To
conduct the biocompatibility test, biological cells were cultured with sterile pieces of PV cells,
and, glue stick in melted form attached with the petridish. During the cell culturing, cell density,
and all other protocols were followed as per ATCC. Cells were rinsed with Dulbecco’s
Phosphate Buffered Saline Solution (DPBS) (Sigma Chemical Inc., St. Louis, MO) and were
monitored visually with a microscope to observe the variation in cell morphology. After 4 days
of incubation in cell culturing medium at 37oC, and 5% CO2 cells were observed microscopically
for viability. Apart from individual culturing of cells with PVs and glues; cells were also cultured
with PV pieces and glues together for biocompatibility test. Figure 4.5 showing the anchorage
depended cells maintained their usual sustainability and confluence in the medium along with
glue, and PV cells were biocompatible in this investigation.

Figure 8: C2C12 Cells are attached and proliferated with PV cell (left) and Glues (right)
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4.3

Sterilizing PV cell
Glue walled PV cells were Ultra Violet (UV)/Ozone cleaned for 2.5 minutes to remove

surface contamination [1]. Subsequently they were soaked in 70% ethanol overnight and air
dried in a sterile ventilated hood. Upon drying, cells were covered with aluminum foil and kept
in the dark to remove electrical charge from the PV devices.

4.4

Experimental procedure
The overall experimental procedure is depicted by flow chart in Figure 4.6. The

experimental procedure is consisting of two steps: one, culturing cells on PV devices and two,
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Figure 9: Flow diagram of working procedure
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Green/Red fluorescence
Live/Dead assay

conducting a cell release from the PV devices by exposing them to light. The release study
protocol is depicted in Figure 4.7. Cell growth curves were evaluated using an MTS assay
(Promega, CellTiter 96, Cat No. G3582) and automated cell counting by Countess® Automated
Cell Counter ( Life technologies, Cat No. C10227).

Methodology
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Figure 10: Schematic of experimental procedure

4.4.1

Cell culture
C2C12 myoblasts cell were cultured until 90% confluence, when medium was removed,

cells were rinsed and washed with DPBS. Washed cells were trypsinized at with 0.1% trypsin
(GIBCO) and incubated for 6 minutes at room temperature. Then they were centrifuged, the
supernatant removed, and the cells re-suspended in media. The cell number was measured with a
hemacytometer using trypan blue staining [2]. Cells were then seeded at the concentration of
20,000 cells/ PV and incubated for one week. All cell-loaded PV devices were placed in a 150
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mm petridish, which was covered with aluminum foil to protect the devivces from accidental
light exposure. Every 24 hours, the cells were counted and release experiments performed.

4.4.2

Releasing cells with light effect
Sub-confluent and confluent cell cultures on PV devices were rinsed three times with

PBS to clean the cells and remove unattached cells. The devices were exposed to light for 1hour,
1.5 hours 2 hours. The experiments were performed every day for seven days. Light intensity
was changed from 200lux to 20000lux. To prevent the cell damage from the heat generated by
the light source and to maintain the temperature at 37±2°C the temperature of incubator was
lowered to 27°C at the beginning of light exposure. The released cells were collected in the
supernatant, centrifuged, and resuspended for counting and other experiments.

4.4.3

Quantification of cells
Cells that adhered to the PV devices after light exposure were rinsed thrice with fresh

medium then collected by trypsinizing and employing cell scrapers. The collected cells were
centrifuged at 1000 rpm for 5 minutes, the supernatant was moved, and the cells resuspended in
fresh medium for cell counting. Cell counting was performed using a Countess® automated cell
counter (Life technologies, Cat No. C10227). Trypan blue (0.4%) and the cell suspension were
mixed well in 1:1 ratio in small vial. 10µl of blue cell solution was loaded in each cell counting
chambers. Single sample measurement provides the live and dead cell concentration/mL, total
cell concentration/mL, and viability (% live cells to total cells), and cell size.

4.4.4

Viability evaluation of the cell suspension arrays
The viabilities of the C2C12 cells attached to PV devices and released from the PV

devices were evaluated by a two-color fluorescence live/dead assay (LIVE/DEAD® reduced
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biohazard Viability/Cytotoxicity Kit #1) and using a solution consisting of SYTO 10 green
fluorescent nucleic acid stain dissolved in DMSO and DEAD read nucleic acid stain dissolved in
DMSO (Invitrogen, Stockholm, Sweden).. Samples were viewed using a fluorescent confocal
microscope Nikon ECLIPSE Ti, and the viability of the cells were evaluated by observing the
number of cells stained with SYTO 10 (green) through the method described in section 4.4.4.1,
As our cell culturing device PV cells are opaque, 4′, 6-diamidino-2-phenylindole,
dihydrochloride (DAPI), a nucleic acid stain was used to visually observe the cell nucleus using
an inverted LSM 700 Zeiss microscope and assisted with ZEN2009 software and the procedure
of DAPI stained, described in section 4.4.4.2.

4.4.4.1

Cell staining for green/red fluorescent
As our culturing surface is non-transparent, live/dead assay of cell was conducted form

centrifuged cell suspension attached on glass cover slip. In case of released cells, centrifuged
cells were sub-cultured on 12-well plate and cells were observed directly from the well plate
rather cover slip. Remove the supernatant from trypsinzed centrifuged cell suspension to leave
the cell pellet only and substitute it with the diluted dye mixture; 200–500 µL should be
sufficient to cover the cell pellet.

4.4.4.2

Fixation and staining cell with DAPI
C2C12 monolayers attached to PV surfaces were washed two times or more with PBS,

maintaining the level at pH 7.4, and ﬁxed with 3.7% formaldehyde followed by incubation for 510 minutes after which formaldehyde was removed, and the cells were rinsed three times with
PBS to stop fixation. After rinsing, the nuclei of the cells were labeled with DAPI (Sigma-
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Aldrich, 300 nM) and incubated for 15-20 minutes. Later the PV surfaces were mounted and
observed under an inverted epifluorescence microscope (Zeiss Eclipse E800).

4.4.5

Statistical analysis
Experimental data are presented as means ± standard deviations, with n = 6 for each

group of the designated number of separate investigations. Statistical assessment was conducted
using unpaired 2-tailed Student’s t-tests between experimental group and control group.
Rejection null hypotheses by P values less than 0.05 (p<.05) were considered signiﬁcant
difference between group. Cells were found in either group under microscopic observation and
cell counting machine conﬁrmed a higher level expression of live release cells, compared with
control cells that were stuck to PV surfaces.
4.4.6

SEM observation
The fixed samples were imaged using HITACHI S- 4800 field emission SEM utilized

electron beam accelerated at 500V to 30kV. Roughly 1cm x1cm sample of PV devices mounted
on a sample holder. There was no special surface coating or polishing required for the sample
preparation.
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Chapter 5: Cell Culture on Photo Voltaic Solar Cells
5.1

Introduction
Cell based therapies are very promising for therapeutic treatment of various diseases and

disorders. Cell therapies offer key advantages that include rapid isolation from the host, in vitro
expansion and delivery to the damaged tissue or organ. Cells in the various forms provide
unique potential to customize treatment of injured tissues or to serve as therapeutic agents. These
cells can be delivered to the site of injury by [1-3] using scaffolds which also provide mechanical
support and serve as substrate for attachment, differentiation, and proliferation [4, 5]. In a
particular application, the cells form sheets, which are thin two dimensional (2D) structures, that
do not require complicated microvasculature and are easily fabricated, but difficult to handle [6].
Therefore, the better option is single cell delivery from biocompatible substrate that doesn’t
require special bio processing or complicated handling mechanism. In our research work, we
used silicon based PV devices that allowed cells to attach and grow. As PV device is photo or
light responsive, electrically excitable cells can be released from the from PV substrate as single
cell due to same electrical charge repulsion.
Silicon is widely used material in biomedical devices used in a wide variety of
applications ranging from devices for functional electrode stimulation[7], to devices for
treatment of Parkinson’s disease [8], to electrode-neuron implants [9], and devices for drug
delivery [10]. In addition, many micro electromechanical systems devices use silicon materials
and are biocompatibile [11]. Fan et al. showed that during implantation of biomedical silicon
devices, sufficient cell attachment to the silicon surface is key [12]. To enhance cell adhesion on
the silicon surface, Maher et al. [13], and Martinoia [14] coated silicon with polylysine, and
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laminin respectively. More cells grew on the coated devices than the silicon alone implants;
however, uncoated silicon is best for cell attachment when it is microstructured.
In this paper, we describe the use of commercially available silicon based photovoltaic
(PV) devices as substrate for culturing of C2C12 mammalian cells by examining the attachment
and growth of the cells. C2C12 is a muscle-like cell line that can form myotubes.

5.2

Material and methods

5.2.1

Materials

5.2.1.1

Silicon substrate preparation
Silicon based photovoltaic (PV) devices that convert the energy of sunlight directly into

electricity by the photovoltaic effect were used as silicon substrate for cell culturing. PV cells,
0.8inch X 1.66inch (2cm X 4cm), were obtained from RadioShack® (Model: 276-124). PV
devices were prepared to avoid medium leakage as described in [15], adding a

nontoxic

biocompatible wall made from glue. Glue walled PV cells were Ultra Violet (UV)/Ozone
cleaned for 2.5 minutes to remove surface contaminations [16]. Subsequently, they were soaked
in 70% ethanol overnight and air dried in a sterile ventilated hood. Upon drying, cells were
covered with aluminum foil and kept in the dark to remove any residual electrical charges from
the PV devices.

5.2.1.2

Cell culture
Anchorage dependent myoblasts C2C12 mammalian were bought from American Type

Culture Collection, ATCC (CRL-1772) grown in Dulbecco's Modified Eagle's Medium (DMEM)
augmented with 1% antibiotics, 2mM glutamine, and 20% fetal bovine serum. The pH was
adjusted to 7.5. Once confluence was reached the cells were washed with PBS, detached from
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petri dish by trypsinizing (.25% trypsin, Sigma Co., St. Louis, MO), counted, and seeded onto
the PV devices @ 20,000 cells/cm2 [17]. The cell cultures were maintained in growth medium
and incubated at 5% CO2, 37°C and 100% humidity changing medium every 24 hours for seven
days.

5.2.1.3 Cell detachment from PV
Cells attached to PV devices were very hard to detach from the substrate. After rinsing
the cells with PBS, 0.75 ml of trypsin was added to the devices, they were incubated for 5-8 mins
and the loose cells were collected. The cells that remained attached to substrates were removed
with a cell scrapper and added to the previously collected cells. A total cell count was then
obtained.
5.2.1.4 Fluorescence staining with green/ red live dead assay
The cells collected from the devices were centrifuged and the supernatant was replaced
by a diluted dye mixture (Component A, Component B, and a FBS as 2:2:1000) and 200–500 µL
were placed on top to cover the cell pellet. After 15 minutes incubation of the dye-cell mixture,
the solution was replaced with fresh PBS, and then 4% glutaraldehyde was added, followed by
15- 20 min incubation after which the cell suspension was pipetted onto a glass cover slip and
observed under epifluorescence.

5.2.1.5 Fixation and staining cell with DAPI
C2C12 cells attached to PV surfaces were washed two times or more with phosphatebuffered saline (PBS), maintaining the pH at 7.4 and ﬁxed with 3.7% formaldehyde for 5-10
minutes. After removing the formaldehyde, the cells were rinsed three times with PBS to stop
fixation. After rinsing, the nuclei of the cells were labeled with 0.1µg/ml DAPI (Sigma-Aldrich,
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300 nM) and incubated for 15-20 minutes. Subsequently, the PV surfaces were washed twice
more with PBS. The samples were then mounted and observed under an inverted fluorescence
microscope (Zeiss Eclipse E800).
5.2.1.6 SEM Sample preparation
Small sections PV devices of (1cm x1cm) were cut out using a sharp knife and were
rinsed with alcohol to avoid any stain or contamination. The samples were then mounted on the
SEM sample holder with double-sided tape. There was no special surface coating or polishing
required for the sample preparation. The samples were imaged using JEOL JSM-7000F Schottky
field emission SEM in combination with Oxford INCA EDS and HKL EBSD systems.

5.3

Result and Discussion

5.3.1

Cell Quantification and viability
An automated cell counter (Life technologies, Cat No. C10227) was used to count live

and dead cell concentrations per milliliter (mL), total cell concentration/mL, viability (% live
cells to total cells), and cell size. Trypan blue stain (0.4%, AMRESCO, Inc, Tissue Culture
Grade) and cell suspensions were mixed well in 1:1 ratio in a cell counting chamber slide. Cell
counts are shown Figure 5.1, depicting ta linear rise of cell numbers for the first 5 days, then an
abrupt decrease.
The growth of cells in culture proceeded from the lag phase following seeding, to
the growth phase, where the cells proliferate linearly. Seeded cells maintained their normal
viability and confluence was achieved by day 5. Following confluency, cells in the medium
clumped together and the medium produces lactic acid due to deposition of metabolic material
waste. Other C2C12 cultures on silicon wafers found confluent cell concentrations of 80,00060
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Figure: 5.1 Cell attachment and growth on the PV surface during 7 day of cell culture. Assessment of
cell density and viability evaluated using trypan blue and cell counting machine. Data presented the
mean± SD, n= 6 .

100,000/sq.cm [12]. However, in our investigation found that maximum cell density on PV
devices were 70,000/ sq.cm, which is on the lower end. These cultures were capable of only a
limited number of cell divisions, after which they entered a nonproliferative stage. In the cell
culture, log phase is missing, because the cell number increased linearly instead exponentially.
This may be due to surface finish as our PV devices were without special coating for rapid cell
proliferation. They are very susceptible to contamination and overgrowth by microbes.
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5.3.2

Light optical microscopy and fluorescence staining with green/ red live dead assay
The C2C12 mammalian cells survived on the silicon surface over more than 7 days after

cell seeding. Observation of the cell cultures under the fluorescent microscope shown in Figure

Green /Red Analysis:

5.2 showed that substantial amount of total proliferated attached cells survived at this time and
Day 5 cell density 120000/ml observation by Green/Red fluorescence microscope

Live cells

Dead cells

Figure: 5.2: Live/Dead assay of attached cell pellet from PV surface at after 5 day of cell seeding.
Cells were trypsinized from the PV
surface and centrifuged the supernatant to get the cell pellet.
© The University of Texas at El Paso
Green /Red fluorescent assay observed by confocal microscope (Density 112000/ml).

attained confluence. The data revealed that the cells could attach and proliferate on the silicon
device. The green in the figure indicates live and metabolically active cells while red indicates
dead cells.

5.3.3

Cell proliferation by DNA observation
DAPI staining of the attached cells shown in Figure 5.3 also proved that the cells adhered

to the silicon devices. Rounded shape of the nuclei is a clear indication of healthy cells and
some cells are seen dividing. Thus, the silicon surface characteristics not only support cell
attachment but also provide a natural environment for cell proliferation and supporting cell
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morphology. It was also noted from the DAPI stain that, while initially the cells were scattered,
eventually, they were able to grow and proliferate as indicated by dividing nuclei and the close
clustering of nuclei seen in Figure 5.3B and Figure 5.3C.

Figure 5.3: 4’,6-diamidino-2-phenylindole (DAPI) labeled nucleic acid stain of C212 cell after cell seeding
on PV surface at different time period (A) 24 hours of cell seeding , cells are just attached to the surface
without proliferation. After cell attachment, cell proliferated with division of nucleolus in Figure B and
C. (B) 3 days of cell culture (C) 5 days of cell culture.

It is noteworthy that cell numbers in Figure 5.3 might be higher than those in Figure 5.1.
This is most likely due to the fact that a significant amount of the cells is lost during the scraping
process or by using trypsin. However, our objective is to demonstrate the cell attachment and
growth profile of C2C12 cells on the PV devices during culture.

5.3.4

Microstructure observation by SEM
An SEM image of the resulting PV surface structure is shown in Figure 5.4. The image

clearly shows the surface features of the devices. The granular appearance of the device surface
indicates that it may be a good substrate for cell attachment, as the roughness may permit seeded
cells to anchor better. Cell density of silicon substrate depends on surface roughness and the
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uniform roughness observed on our devices could be another reason why our cell densities are

Figure 5.4: Scanning Electron Micrographs (SEM) of silicon PV surface,
showing the regular granular microporous silicon surface structure.

lower than the literature values. In order to increase cell attachment, one may coat the surface
with cell adhesion proteins. Nevertheless, we have shown that the PV devices can serve as cell
substrates or cell carrier physiological conditions that mimic in vivo condition [18].

5.4

Conclusions
We demonstrate that porous silicon surfaces of PV devices can be used as cell culturing

substrates or scaffold. We also showed that the PV devices are biocompatible and support the
growth of mammalian cells but limited the total number of cell even in confluent level.
Traditionally, PV cells have been used as a clean renewable source of energy. This study
explored the biological applications of silicon based PV devices. However, lot of issues need to
addressed to achieve optimum cell growth such surface modifications, or addition of special
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coating. Further formulation optimization studies are needed to improve the efficiency of cell
attachment and viability. This investigation suggests that microstructured silicon is very
promising biomaterials that can potentially be used as cell carrier or vehicle for the delivery of
cells and therapeutics.
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Chapter 6: A Novel Cell Release System from The Photovoltaic Surface Using
Light Source as External Stimulation

Cell therapy is a biomedical technology in which cells are delivered to an injured or
diseased organ either individually, collectively as aggregates or sheets, or encapsulated with a
scaffold. Some of the delivered cells attach, proliferate, and differentiate and aid in regeneration
of the damaged tissue or organ. The effectiveness of the therapy depends amongst others on how
controlled the release of cells to the targeted area is. The objective of our study was to investigate
the release of cultured cells from silicon based Photovoltaic (PV) surfaces using a light source as
external stimulation. C2C12 skeletal muscle cells were cultured on the negative surface of a PV
device and upon confluence they were exposed to light and the amount of released cells were
quantified as a function light exposure. It was found that light exposure at 25000lux caused
significantly cell release from the PV surface. This mechanism may offer an alternative method
to release excitable cells without using an enzymatic release method.

6.1

Introduction
In cell expansion, a large amount cells are produced by sub-culturing or splitting from

mother cells. A small number of detached cells can then be used to seed a new cultures, while the
remainder are used for storage, further processing or cell therapy. For adherent cultures, cells
first need to be detached from the culturing surface commonly done with trypsin, EDTA, or a
combination of both. Trypsin is an endopeptidase produced by the gastro-intestines of mammals.
In cell culture, it is used to permeabilize because it hydrolyzes the membrane peptides. This
digestion can result in a substantial amount of cell death if trypsin exposure is too long. In
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addition to trypsin, EDTA, a chelating agent is often used to accelerate cell detachment and
reduce the harsh effect of trypsin alone. One of the disadvantages of EDTA is the slow action of
this agent. The main drawbacks of using enzymatic cell detachment techniques are cost and the
necessity of removing the enzyme from the culture after digestion. In addition, enzymatic
methods are not applicable for all cells.
Engineering cell release methods without using enzymatic techniques are alternatives that
may improve cell detachment without causing damage to cell membrane proteins. Those
strategies have in common that they use some external stimulation upon which the cells detach
either as single cells, as aggregates or as sheets, Various external stimuli have been used such as
magnetic force [1], temperature reduction [2], thermal on-off mechanism on Poly(N-isopropyl
acrylamide) (PIPA Am) grafted surface [3], and electro chemical stimulation [4]. Magnetic
labeling of cells is very complicated and it can lead to inhomogenious rather than uniform
release. Thermal reduction can induce cold stress due to rapid temperature reduction,and this
may interfere with normal biological function. Electrochemical detachment requires accurate
adjustment electro kinematic forces during the release process, which is difficult to perform.
In our research study, we used a modification of the electrochemical method, where the
electric charges are created using silicon based PV devices. The main characteristic of PV
devices is their generation of voltage with the light exposure by photovoltaic effect (PVE) [5].
PVE induces negative and positive voltage on n-type region and p-type region of the devices [6].
On the other hand action potential based electrically excitable cell such as cardiomyocytes have
polarized membranes [7]. We hypothesize that by exposing electrically excitable cells grown on
PV devices to light, enough electromotive forces are generated to release some cells from the
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culturing surface in a novel non-invasive way. To proof this concept we evaluated the effect of
external light on a model cell line, the mouse myoblast cell line C2C12, grown on PV devices.

6.2

Experimental

6.2.1

Preparation of silicon PV cell
Silicon based PV devices in the dimension of 2cm X 4cm were obtained from

RadioShack® (Custom assembled in USA, Model: 276-124). A nontoxic biocompatible glue
wall was provided surrounding the PV devices to avoid cell culturing liquid medium spillage. PV
devices were sterilized exposing to Ultra Violet (UV)/Ozone chamber for 2.5 minutes to remove
surface contamination [8]. Subsequently, they glue walled PV devices were soaked in 70%
ethanol overnight followed by air drying in a sterile ventilated hood. To conduct experiments, 6
devices were placed in 150mm petridish and fully covered with aluminum foil in the dark to
avoid any incidental surface charges on the devices.

6.2.2

Cell culture and light exposure of PV devices.

C2C12 cells were acquired from American Type Culture Collection, ATCC (CRL-1772) grown
in Dulbecco's modified Eagle's medium (DMEM) augmented with 1% antibiotics, 2mM
glutamine, 10% fetal bovine serum, and the pH was adjusted to 7.5. Confluent cultures washed
with PBS, trypsinized (0.25% trypsin, Sigma Co., St. Louis, MO), counted , and the cells were
seeded the PV devices at densities of 20,000/cm2 [9]. The cell cultures were maintained in
growth medium and incubated at 5% CO2 37°C, and 100% humidity. Every 24 hours cells were
rinsed with PBS followed by growth medium change as required. Upon confluence of cell
culture, PV devices were split in two groups; group 1 for light exposure and group 2 unexposed
to light. Figure 6.1 details the cell culture protocols followed. PV devices of group 1 were
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exposed to light from a light emitting diode at 700nm and intensity of 2500lux, which
corresponded to a voltage generation of 0.35Vdc on the device surfaces. Devices were left under
the light source for 1, 1.5, and 2 hours. To prevent cell damage from the heat generated by the
light source, the incubator temperature setting was lowered to 26°C 1 hour prior to light exposure
and sterile ice cubes were placed under the light and top of the petridish cover to balance local
temperature using latent heat of melting. This kept the media temperature at at 37±2°C once the
light source was turned on. Any released cells were collected in the supernatant, centrifuged and
counted.
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Medium#w#cells#2ml#
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Add#new#medium#
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Remove#medium#

Incubator##
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collected#from#PV#devices#

StaCsCcal#and#microscopic##analysis#of#cells#

Figure 6.1: Pictorial diagram of cell release by light effect

71

Incubate##in#dark#

6.2.3

Fixation and staining cell with (DAPI)
PV surfaces with C2C12 cells were rinsed twice or more with PBS, and ﬁxed with 3.7%

formaldehyde for 5-10 minutes. Formaldehyde was then removed by rinsing three times with
PBS to stop fixation. The nuclei of the cells were labeled with 0.1µg/ml DAPI (Sigma-Aldrich,
300 nM) and incubated for 15-20 minutes. Then the devices were rinsed and observed under an
inverted fluorescence microscope (Zeiss LSM 700)

6.2.4

Cell staining for green/red fluorescent:
Mixture of Green/Red dye with PBS (Green: Red: PBS = 1:1:500) added to the cell pellet

in a centrifuge tube just to cover the cell pellet and incubated for 15 mins in the dark. Fresh PBS
and 4% glutaraldehyde was added to the cell pellet after removing dye mixture and again
incubated for 15-20 mins. After thoroughly mixing of the cell pellet with PBS solution in cell
suspension, the required amount of stained cell suspension was put on glass cover for Live/ Dead
Assay analysis.

6.3

Result and discussion

6.3.1

Cell Release by Light Exposure
Figure 6.2 shows the comparison of cell release by the trypsin and light exposure for 1,

1.5 and 2 hours. We used normal PV devices available commercially for solar power generation.
There was no special surface treatment or any protein layer added to the PV devices. Only 46%
cells released from the devices using trypsin, the remainder cells were still attached to the
devices.. With 1 hour of light exposure maximum roughly 38% of the cells released which is
somewhat lower than the number released with trypsin. Also seen from the figure is that less
cells released with longer exposure. This is an artifact, which we attribute to decreased cell
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viability with increased exposure. This may be due to the fact that the cells were only collected at
the endpoint of the experiment. The anchorage dependent C2C12 cells may undergo apoptosis
when in suspension for over one hour detaching from culturing substrate or extra cellular matrix
[10]. Another potential cause may be damage due to the heat of the light source, although we
tried to mitigate this effect as much as possible.
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Figure 6.2. Quantification of C2C12 cell released with light exposure, and trypsin after 5 days of cell
culture. Cells were released from the PV devices by light exposure at 25000lux. For the light
mediated cell release, quantification done only for the live cells.
	
  

commercially for solar power generation. There was no special surface treatment or any protein
layer added to the PV devices. As a result only 46% cells released from the trypsinization
process. Rest of the cells closely attached to the PV surface due to surface properties of PV
devices. With light exposure it is shown in the Figure 6.2 that compare to trypsin cell released is
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low. With 1 hour of light exposure maximum 38% cell release due to same charge repulsion.
Experimental data showed that with more light exposure time cell release remain almost same,
however, viability decreases with time. This may be due to anoikis or program cell death caused
by anchorage dependent cell detaching from the substrate material. Another potential cause may
be damage of heat shock protein due to prolonged light exposure due to temperature rise in
culturing medium.
Although we do not know the exact mechanism for the cell release, we propose the
following mechanism as shown in Figure 6.3. Light exposure created negative (-ve) surfaces of
the PV devices [11] by PVE. When at rest, the potassium ion channels in C2C12 cells are open

Figure 6.3: Kinetics of cell detachment mechanism for electrically excitable cells from PV devices.
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allowing K+ ions to leave the cells for a resting voltage of -15mV [12], [13]. The negative
voltage on the PV surface upsets the equilibrium, by either sequestrating K+ ions inside the cells,
or by repelling anions in the solution. C2C12 cells have been shown to exhibit hyperpolarization
of up to of -75mV when stimulated by extracellular 5′-guanosine-triphosphate (GTP) [14]. We
do not know if the surface potential also induces intracellular Ca2+ mobilization, but this could be
a possibility. The following contraction of the cells may lead to release from the surface.
Other factors that could contribute to cell release in this case is same charge repulsion
[15]. Many of the aspects of the proposed mechanism still need to be investigated, however, it is
clear that a substantial amount of viable cells are released upon light exposure.

6.3.2

Cell release and retention by nuclei staining
Comparing the two groups, more than 24,000 cell/sq.cm were released in the group

exposed to light than from the devices were kept in dark. Consequently, after light exposure PV
device should have less number of attached cells in comparison with dark group. Figure 6.4,
shows DAPI staining of cells that remained attached to the devices after 1.5 hours of light
exposure compared to the control group. On the devices from group1 about 46,000 cells/cm2
remained in the devices compared to, 72,000 cells/ cm2 on the control group, which means that
roughly 36% of the attached cells were released. These DAPI results compare well with the 38%
released cells that were counted in the supernatent. The nuclei in Figure 6.4, lacked regular
circular shape, but this may be due to fixation, and permeabilization procedures, which can cause
artificial distortion of nuclei [16]. The distinctive clustering behavior of the nuclei may be due to
cell division and or too strong attachment of the cells to the PV substrates.
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Figure 6.4: Fluorescent microscopy of cell attached PV devices as cell culturing substrates. Round
shaped DAPI stain represent cellular nucleolus. In the Figure comparison is shown between two
subgroups of PV devices. (a) C2C12 cells from group 1 after 1.5 hour exposure leaving comparatively
few nuclei (36). (b) C2C12 cells from group 2 show large number (50) of nuclei per unit area.

Figure 6.5 shows the cell retention capacity of two groups of PV devices. A student t test
supported the rejection of null hypothesis that light effect on dark group, and light group is not
equal and show a significant (p=0.00014).
Figure 6.6a shows viability of released cells from the PV devices. The image cleary reveas
very few dead cells (red) and most of the cells are live (green) resulting in high cell viability.
This is an initial indication that the cell membranes remained intact upon release. Figure 6.6b
shows a live dead image of reeased cells that were cultured for after 72 hours. Cells were well
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attached to the petridish and showed normal phenotype. This indicates that the released cells
maintained their normal growth profile and cells could be used further studies.
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Figure 6.5: Cell retention data was collected from the PV devices and conducted a student t test. For
the light group after cell releasing upon light exposure for one hour at 25000lux, remaining attached
cells were collected from the PV devices and compared with cells count in the dark group using the
Student t test.

Combined, these observations suggest that light could significantly effect on release of
C2C12 cells without utilization of trypsin. Device may further be improved by coating with
Poly-L-Lysine (PLL) or Bovine Serum Albumin (BSA) [17]. Furthermore, reuse of PV devices
reduced the cell attachment and release capacity potentially due to cell membrane protein
deposition and erosion of surface.
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Figure 6.6: (a) Viability/cytotoxicity staining of C2C12 on cell pellet released from light effect.
Dead cells are stained in red and live cells are stained in green. The scale bar is 100 μm;
(b) C2C12 released by light exposure cultured for 72 hours on 12 wellplate.

6.4

Conclusion
PV devices without surface coatings were used as substrates to culture C2C12 cells. In

our experiment we have found that cell attachment on the PV device was 70,000/sq.cm and out
of them maximum 38% cells were released by light exposure. To achieve better result
modification of PV surfaces such cell adhesive coating with robust cell-repellent agent by light
exposure can be used. Our hypothesis was based on the same charge repulsion by cell membrane
voltage (Vm) and voltage of PV surface. For electrically excitable cells, Vm depends on
transmembrane ionic concentration and gradient that led excitability as well as the depolarization
and repolarization. To get the acute result, real time Vm , and ionic concentration need to measure
and monitor to correlate with PV voltage. One of the major drawbacks of our pilot study was the
selection of light source without heat generation to get designed output voltage 0.5V compare to
0.35V. Also more studies and research are needed to manufacture biocompatible PV devices that
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show surface voltage with optimum surface texture compatible with cell culture and release by
PVE.
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Chapter 7: Photo Responsive Coated Sustainable Novel Petridish for
Electrically Excitable Cells

Over more than a century the disposable petridish has become an indispensable lab ware
in biological laboratory work for cell culture. Disposable dishes potentially waste a large amount
of resources, contribute to an ecological imbalance and add to landfills. Sustainable reusable
dishes for culturing cells would be a solution to this problem. We propose to use a reusable
petridish-like device based on PhotoVoltaic (PV) devices. The device surface provides an
environment for cells to attach, differentiate, and proliferate. Prior investigations revealed, that
upon confluence, light exposure to the device surface releases substantial amount of cells by
PhotoVoltaic Effect (PVE). Here we show that the remaining cells on device surface could
further proliferate to be released later. Direct cell counting and microscopic observation showed
that released cells were able to maintain their regular growth profile. Therefore, present pilot
study suggests that we made a continuous cell culturing device that may facilitate expansion,
screening, counting, and selection.

7.1

Introduction
Cell culture is a series of processes such as cell isolation, cell seeding, and cell attaching

on sterile cell friendly surfaces in controlled environment. During culture, cells are seeded on
dishes or in flasks to attach, differentiate, and proliferate. Culturing cells or microorganism in a
dish that contain liquid growth media would be first recognized by Robert Koch during the
growth of bacteria into a colony in the 19th century [1]. Currently used specially coated dishes
are shallow cylindrical lidded products made of high quality glass or polystyrene materials. The
latter are disposable products and those are widely used in laboratory practices. Culturing cells
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on disposable dishes is an expensive and labor-intensive proposition [2-3]. Disposing of these
dishes also cost huge amount of money, and natural resources all over the world every year due
to intense biological, and medical research.
Modern manufacturing technologies can reduce the cost of disposable dishes, however,
the disposing trypsin mediated cell processing equipment remains expensive. In the US alone,
0.22 million tons of disposable plastic labware are produced each year and the associated cost for
waste management and recycling is approximately $99.5 million [4]. Recently, researchers have
developed highly porous dishes [5] to increase the efficacy of cell processing as well as cell
viability. These highly microporous dishes are reliable and robust, and permit many of the
manipulation required in cell culture. Drawbacks are the high cost and the incompatibility with
some microbial species. Exceptionally porous (40% by volume) aluminum oxide (PAO) coated
petridishes can be used as a microbial culture support [6–8]. These devices have nano-range
pores (20–200nm) and are capable of retaining cells on their surface. However, these dishes are
fragile, not user friendly, and cannot compete on cost. Microtissues Inc., Rhode Island,
(Microtissues.Com) invented Scaffold free 3D petridishes by micro mold technology that
facilitate scaffold free high cell-cell interactions. The micro-molds are autoclavable and reusable,
but cost is very high. Also bioprocessing and storage of single cells is not possible using these
dishes. Other advances include the use of very light durable polystyrene dishes, but the disposal
and recycling of these remain an issue. Therefore, it is important to develop sustainable reusable
petridishes that can be sterilized easily and can be used repetitively.
To address the above issues we investigated sustainable petridishes based on silicon PV
devices. The devices are capable of producing electric voltage when they are exposed to visible
or infrared light [9], [10]. In our previous studies cells were seeded on PV substrates, and
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incubated in incubator to attach, and proliferate. Upon confluence, the devices were exposed to
light producing a negative voltage on silicon surface. As result cells detached form the surface,
and floated in in the growth medium. The remaining cells were analyzed and appeared normal
apart from some minor changes in nuclei shape, which we attributed to fixing and staining
artifacts. In this study we will examine if the remaining cells are able will proliferate further and
if the release can be performed periodically between periods of growth. .
Trypsin mediated cell release from disposable dishes is widely used. [14-16], Trypsin is
a pancreatic serine protease that hydrolyzes polypeptides. Excreted by the pancreas, trypsin has
the capability of breaking down proteins, into small peptides [13]. In the cell culture process,
trypsin is used to detach adherent cells, by breaking down the proteins responsible for cell
attachment [17]. As a result, cells are disengaged from each and the substrate. Trypsin mediated
cell detachment is invasive mechanism. During the digestion, , the membrane proteins become
damaged and prolonged trypsinization leads to irreversible cell damage. To avoid the harsh
trypsin affect, accutase, another cell detachment enzyme, which shows a mixture of proteolytic
and collagenolytic activity, is used in laboratory practices [18].

Similarly nonhuman or

nonanimal, trypLE Select®is also used to in place of trypsin [19]. Even though these enzymes
are comparatively less harmful than trypsin, the use of disposable petridishes and a major
concern.

7.2

Materials and methods

7.2.1

Preparation of silicon PV petridish
PV devices that convert the energy of sunlight directly into electricity by the photovoltaic

effect were used as cell culturing substrate. Sing crystal structured PV devices made from silicon
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(size: 2cm X 4cm) were obtained from electronic retail store RadioShack® (Custom assembled
in USA, Model: 276-124). PV devices were prepared to avoid medium leakage adding a
nontoxic biocompatible wall made from glue. Glue walled PV cells were UV/Ozone cleaned for
2.5 minutes to remove surface contaminations [11]. Subsequently, they were soaked in 70%
ethanol overnight and air dried in a sterile ventilated hood. Upon drying, cells were covered with
aluminum foil and kept in the dark to avoid any incidental electrical charges on the device
surfaces.

7.2.2

Cell culture
The mouse C2C12 myoblast cell line was purchased from American Type Culture

Collection, ATCC (CRL-1772). Cells were grown in Dulbecco's Modified Eagle's Medium
(DMEM) augmented with 1% antibiotics, 2mM glutamine, 10% fetal bovine serum, and the pH
was adjusted to 7.5. Confluent cells were washed with PBS, trypsinized (.25% trypsin, Sigma
Co., St. Louis, MO), counted, and seeded cell on the PV devices at concentrations of 20,000/cm2
[12]. The devices were placed into a polystyrene dish and maintained in medium and incubated
at 5% CO2, 37°C, and 100% humidity. Every 48 hours cells were replenished with growth
medium as per manufacturer’s instructions.

7.2.3

Light exposure
Upon confluence of cell culture, and then periodically every five days, the devices were

exposed to light at various intensities summarized in Table 7.1, for 1 hour. To prevent cell
damage from the heat generated by the light source, the incubator temperature setting was
lowered to 26°C 1 hour prior and sterile ice cubes were placed under the dish. This kept the
media temperature at 37±2°C once the light source was turned on. Any released cells were
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collected in the supernatant, centrifuged and counted. After cell release, the remaining cells on
the PV devices were further incubated at 5% CO2, 37°C, and 100% humidity. Figure 7.1 depicts
the schematic sequence of the release experiments.

Table 7.1: Various lights used for PV effect for cell released

Light Intensity

Type of light

Generated voltage (V)

Voltage (mV)/cm2

2000lux

Fluorescent

0.15

27.8

15000lux

Visible light

0.3

55

25000lux

LED

0.35

64.8

200lux

Infra-red

0.5
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Figure 7.1: Successive cell release mechanism from PV devices upon light exposure
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7.2.4

Cell analysis and microscopy
Cell counts were obtained using a Countess® automated cell counter (Life technologies,

Cat No. C10227) that allowed comparing cell release, total cells number, and viability of cells at
each release experiment. Released cells were collected, cultured on regular dishes and their
morphology assessed by optical phase microscopy,
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Figure 7.2: Cell culture and release of C2C12 cell from PV devices

7.3

Result and discussion

7.3.1

Cell retention in PV substrate and light exposure cell released
Both enzymatic and nonenzymatic methods can be used for cell release from PV devices.

Enzymatic process, for example trypsin is harsh and may damage the cell membrane. In this
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study, we used novel non-enzymatic process to release cell from the substrate. Figure 7.3
showing cell release comparison between trypsin, and light. In the both cases a significant
amount of cells were released, but, more than 50% cells retained to the PV substrates. The light
exposure process is noninvasive process to release cells as it doesn’t damage the cell membranes.
As a result, the cells that remain attached can easily grow and proliferate further.
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Figure 7.3: Cell release from the PV devices via trypsin and light exposure. Significant amount of ells retained
to the PV devices by both enzymatic and non enzymatic process were compared with released cells. Cells
count varies from the previous study due to reuse and/or different lot of PV devices.

7.3.2

Successive cell release from PV devices
Figure 7.4 shows cell counts of cells on PV devices as function of time. It was evident

from the figure, that cells can be successively released from the devices using light exposure. At
day 6, the total number of cells was 70,670 and the number of remaining cells after release was
44,300; the figure also shows the total number of cells released decreases.
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In general, the figure shows that after initial seeding, the cells proliferated, and continued
to do so for 26 days, when the experiment was stopped. However, we can also observe that the
rate of proliferation slows down after each release step. This could indicate that the substrates
become increasingly covered with extracellular matrix but it could also be the result of some
transformation of the cells. Another potential explanation may be that the devices effect the
transmembrane potential of the C2C12 cells on PV substrate, thus affecting mitosis, DNA
synthesis, cell cycle progression, viability and metabolism [20-21]. We will study the reason for
the decreased proliferation rates later.
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Figure 7.4: To analyze the effects of light on the cell release mouse myoblast C2C12 cells were cultured
on the PV devices. Upon confluent in stability phase, cells were release by light exposure (25000lux for 1
hour) and remaining nonreleased cells attached PV were incubated for confluence and successive cell
release. At day 6 total number of cells were 70670 at confluent stage and due to light exposure cells were
released remaining cells number attached to PV were 44300; therefore total cell released was 26370
(70670 – 44300). Figure also showing the total number of cells decreases at stability phase due to protein
deposition on the surface.
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As light stimulated process is noninvasive, it didn’t damage any cell membrane protein or
peptides of the released cells or the cells remaining attached to the devices. In addition, the light
does not affect the substrate topography, and as a result, the same device can support continued
cell growth and proliferation.
Figure 7.5 shows the relation between the voltage generated by the PV devices and
percentage of released cells. These data suggest that the cell release is proportional to maximum
voltage generation capacity of the PV device, The highest cell release with acceptable cell
viability was for a 1 hour exposure at 25,000 lux; the release rates were higher for a 200 lux IR
exposure, but the viability of the released cells was marginal (~20%). Rapid heat generation by
the IR light may be responsible for damaging the released and attached cells.. Although we do
not know the exact mechanism for the cell release, we propose the following mechanism. Light
exposure created negative (-ve) surfaces of the PV devices. When at rest, the potassium ion
channels in C2C12 cells are open allowing K+ ions to leave the cells for a resting voltage of 15mV [11], [12]. The negative voltage on the PV surface upsets the equilibrium, by either
sequestrating K+ ions inside the cells, or by repelling anions in the solution. C2C12 cells have
been shown to exhibit hyperpolarization of up to of -75mV when stimulated by GTP [22]. We
do not know if the surface potential also induces intracellular Ca2+ mobilization, but this could be
a possibility. The following contraction of the cells may lead to release from the surface [2].
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Figure 7.5: Cell release comparison with generated voltage of various intensities of light. For each
light source, exposure time 1 hour except for IR light (5 mins). Cell viability was only 20% for IR
light.

Figure 7.6 shows morphologies of released cells that were subsequently cultured in
regular plates. There are no distinct difference between cells released with trypsin and those
released by light exposure. This suggested that cells released by light exposure from PV surface
are not transformed and maintain their phenotype.
Full phenotypical characterization of the C2C12 cells still needs to be done and the
ability of the released cells to differentiate into myotubes should also be investigated before
concluding that the light release technique is as useful as trypsination. Other potential problems
for future studies are to measure the effect of the PV devices on the cell membranes by either
using voltage-sensitive fluorescent dyes [23] or microelectrode insertion patch clamping [24].
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We also plan to conduct Ca imaging studies to verify our release hypothesis. In addition, one
could investigate if collagen or fibronectin coating of the devices will improve cell proliferation
after successive releases.

a"

b"

c"

d"

Figure 7.6: To investigate whether the light stimulated released cells can maintain their viability
such as attachment, and proliferation, C2C12 cells were seeded in 6-well plates with DMEM and
incubated in a incubator for optical microscopic observation. (a) Cell attachment after 6 hours of
cell seeding. (b) 24 hours of cell culture. (c) 48 hours of cell culture. (d) 72 hours of cell culture.

For over a decade global leaders were focusing on developing green technology including
green manufacturing process to reduce pollution and dependency on natural resources.
Biomedical engineering is rapidly growing field and a growing part of the global economy
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Reusable cell culture substrates, as those investigated here, could paly an important role in
replacing disposable culture dishes without utilization cell unfriendly trypsin. Although the usage
of disposable dishes seems economical, using trypsin in cell processing is time consuming and
tedious process and the cost of disposing are still very high. Reusable sustainable culture dishes
will, in the long run, save energy, raw materials and disposing costs. As the total land, and
natural resources of the world is limited, production and disposal waste management practices
affect a large regional population. Using reusable petridish will prevent environment pollution
such as reduce usage of energy, water, solid waste and eventually total manufacturing costs [25].
7.4

Conclusion
We have developed an environmentally sustainable and less hostile methods for culturing

and subculturing C2C12 cells that is a novel way of releasing cells for analysis, including cell
delivery.. Using PV devices, we have shown that 37% of attached C2C12 cells could be released
upon light exposure. The remaining cells continue to grow until a new release episode. This
continuous growth and release was repeated for 30 days with only minor slowdown in growth
rates.

The released cells showed normal morphology. In addition to being a reusable,

environmentally friendly system, the idea of a continuous cell culture that does not involve
bioreactors is attractive and may open the door to many fields in which large expansion of cells
are needed.
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